134 related articles for article (PubMed ID: 9027320)
1. Characteristics of tumor cell bioactivity in oncogenic osteomalacia.
Nelson AE; Namkung HJ; Patava J; Wilkinson MR; Chang AC; Reddel RR; Robinson BG; Mason RS
Mol Cell Endocrinol; 1996 Nov; 124(1-2):17-23. PubMed ID: 9027320
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of renal epithelial phosphate transport in tumor-induced osteomalacia and uremia.
Kumar R; Haugen JD; Wieben ED; Londowski JM; Cai Q
Proc Assoc Am Physicians; 1995 Oct; 107(3):296-305. PubMed ID: 8608414
[TBL] [Abstract][Full Text] [Related]
3. Extracts from tumors causing oncogenic osteomalacia inhibit phosphate uptake in opossum kidney cells.
Jonsson KB; Mannstadt M; Miyauchi A; Yang IM; Stein G; Ljunggren O ; Jüppner H
J Endocrinol; 2001 Jun; 169(3):613-20. PubMed ID: 11375132
[TBL] [Abstract][Full Text] [Related]
4. Effect of synthetic tumoral PTH-related peptide on cAMP production and Na-dependent Pi transport.
Pizurki L; Rizzoli R; Moseley J; Martin TJ; Caverzasio J; Bonjour JP
Am J Physiol; 1988 Nov; 255(5 Pt 2):F957-61. PubMed ID: 2847553
[TBL] [Abstract][Full Text] [Related]
5. Effect of dexamethasone on parathyroid hormone (PTH) and PTH-related protein regulated phosphate uptake in opossum kidney cells.
Kaufmann M; Muff R; Fischer JA
Endocrinology; 1991 Apr; 128(4):1819-24. PubMed ID: 1848502
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by (D-Trp12,Tyr34)bPTH(7-34)amide of PTH and PTHrP effects on Pi transport in renal cells.
Pizurki L; Rizzoli R; Bonjour JP
Am J Physiol; 1990 Aug; 259(2 Pt 2):F389-92. PubMed ID: 2167018
[TBL] [Abstract][Full Text] [Related]
7. Cloned, stably expressed parathyroid hormone (PTH)/PTH-related peptide receptors activate multiple messenger signals and biological responses in LLC-PK1 kidney cells.
Bringhurst FR; Juppner H; Guo J; Urena P; Potts JT; Kronenberg HM; Abou-Samra AB; Segre GV
Endocrinology; 1993 May; 132(5):2090-8. PubMed ID: 8386606
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase-A and the effects of parathyroid hormone on phosphate uptake in opossum kidney cells.
Martin KJ; McConkey CL; Garcia JC; Montani D; Betts CR
Endocrinology; 1989 Jul; 125(1):295-301. PubMed ID: 2544405
[TBL] [Abstract][Full Text] [Related]
9. Response of immortalized murine cementoblasts/periodontal ligament cells to parathyroid hormone and parathyroid hormone-related protein in vitro.
Ouyang H; McCauley LK; Berry JE; D'Errico JA; Strayhorn CL; Somerman MJ
Arch Oral Biol; 2000 Apr; 45(4):293-303. PubMed ID: 10708669
[TBL] [Abstract][Full Text] [Related]
10. Stimulation by parathyroid hormone-related protein and transforming growth factor-alpha of phosphate transport in osteoblast-like cells.
Pizurki L; Rizzoli R; Caverzasio J; Bonjour JP
J Bone Miner Res; 1991 Nov; 6(11):1235-41. PubMed ID: 1666809
[TBL] [Abstract][Full Text] [Related]
11. Phosphate wasting in oncogenic osteomalacia: PHEX is normal and the tumor-derived factor has unique properties.
Nelson AE; Hogan JJ; Holm IA; Robinson BG; Mason RS
Bone; 2001 Apr; 28(4):430-9. PubMed ID: 11336925
[TBL] [Abstract][Full Text] [Related]
12. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
McKee RL; Goldman ME; Caulfield MP; DeHaven PA; Levy JJ; Nutt RF; Rosenblatt M
Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone-induced calcium release from intracellular stores in a human kidney cell line in the absence of stimulation of cyclic adenosine 3',5'-monophosphate production.
Jobert AS; Leroy C; Butlen D; Silve C
Endocrinology; 1997 Dec; 138(12):5282-92. PubMed ID: 9389512
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of parathyroid hormone analogs in the opossum kidney cell line.
Cole JA; Carnes DL; Forte LR; Eber S; Poelling RE; Thorne PK
J Bone Miner Res; 1989 Oct; 4(5):723-30. PubMed ID: 2554688
[TBL] [Abstract][Full Text] [Related]
15. Tumor expression studies indicate that HEM-1 is unlikely to be the active factor in oncogenic osteomalacia.
Nelson AE; Mason RS; Hogan JJ; Diamond T; Robinson BG
Bone; 1998 Dec; 23(6):549-53. PubMed ID: 9855464
[TBL] [Abstract][Full Text] [Related]
16. Regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid by glucocorticoids and PTH in ROS 17/2.8 and OK cells.
Ureña P; Iida-Klein A; Kong XF; Jüppner H; Kronenberg HM; Abou-Samra AB; Segre GV
Endocrinology; 1994 Jan; 134(1):451-6. PubMed ID: 8275958
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic osteomalacia: evidence for a humoral phosphaturic factor.
Wilkins GE; Granleese S; Hegele RG; Holden J; Anderson DW; Bondy GP
J Clin Endocrinol Metab; 1995 May; 80(5):1628-34. PubMed ID: 7745010
[TBL] [Abstract][Full Text] [Related]
18. Parathyroid hormone (PTH) down-regulates PTH/PTH-related protein receptor gene expression in UMR-106 osteoblast-like cells via a 3',5'-cyclic adenosine monophosphate-dependent, protein kinase A-independent pathway.
Kawane T; Mimura J; Yanagawa T; Fujii-Kuriyama Y; Horiuchi N
J Endocrinol; 2003 Aug; 178(2):247-56. PubMed ID: 12904172
[TBL] [Abstract][Full Text] [Related]
19. Actions of parathyroid hormone and parathyroid hormone-related protein.
Rizzoli R; Ferrari SL; Pizurki L; Caverzasio J; Bonjour JP
J Endocrinol Invest; 1992; 15(9 Suppl 6):51-6. PubMed ID: 1338636
[TBL] [Abstract][Full Text] [Related]
20. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
Behar V; Pines M; Nakamoto C; Greenberg Z; Bisello A; Stueckle SM; Bessalle R; Usdin TB; Chorev M; Rosenblatt M; Suva LJ
Endocrinology; 1996 Jul; 137(7):2748-57. PubMed ID: 8770894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
